from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3026c/-

LFCtreatmentdescriptionclass of inhibitor

-0.307

Amikacinug/mL Amikacintranslation

0.173

Cap5-10ug/mL Capreomycintranslation

-0.069

Rox10-50 ug/mL Roxithromycintranslation

-0.250

SM2-5 ug/mL Streptomycintranslation

0.310

Tet5-10 ug/mL Tetracyclinetranslation

0.471

Rif0.2-5ug/mL Rifampicintranscription

0.065

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.058

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.357

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.030

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.072

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.046

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.762

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.009

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.567

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.107

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.224

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.421

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.531

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.118

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.563

Nigericin50 uM Nigericinrespiration

0.426

TRC10-150 ug/mL Triclosanrespiration

-0.116

TRZ10-25 ug/mL Thioridazinerespiration

0.158

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.065

menadione6-10 ug/mL Menadionerespiration

-0.112

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.109

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.144

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.504

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.440

NRP_1Non-replicating persistence stage 1dosRassociated

-0.163

Amp0.2mg/mL AmpicillincellWall

-0.571

Cephalexin20-100 ug/mL CephalexincellWall

-0.545

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.782

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.034

EMB10-20 ug/mL EthambutolcellWall

-0.817

Eta12-40 ug/mL EthionamidecellWall

-0.998

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.014

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.387

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.834

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.235

BZA0.12 mg/mL BenzamidearomaticAmides

0.596

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.221

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.456

H2O24 mM hydrogen peroxideDNAdamaging

-0.211

Levo10 ug/mL LevofloxacinDNAdamaging

0.693

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.394

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.396

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.497

UVUV-irradiationDNAdamaging

-0.452

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.384

Antimycin12.5-50 ug/mL Antimycin A?

-0.658

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.261

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.008

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.288

PA8240.2-2 ug/mL PA-824?

1.323

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.021

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.550

Verapamil50 uM Verapamil?

-0.731

mercaptoethanol2 mM 2-Mercaptoethanol?

0.165

methoxatin10-20 ug/mL Methoxatin?